This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The rising recorded death rate from cancer is a definite evidence that treatment of the disease is as yet very defective. Granted that this increase in the death rate is largely due to improved diagnosis, it would seem reasonable to assume that such improvement in diagnosis should detect a larger number of operable cases and thus afford better material for treatment. Obviously, this is not the case. On the other hand, statistical
studies of large series of treated patients are now available showing very good results in certain types of cancer, such as those of the skin, breast, uterus and lip; yet the death rates in these favorable sites are not falling. Is this due to incompetent treatment by the physicians of the country or to the fact that the material is hopeless from the start? Are not the favorable statistical collections from selected groups of patients, and are they
SHORE BR. OPERABILITY IN CANCER: STATISTICAL STUDY OF ONE THOUSAND CASES. JAMA. 1928;90(21):1690–1692. doi:10.1001/jama.1928.02690480012005
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: